ADA Linagliptin in Long Term Care
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT02061969
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Registry
-
NCT02061969
-
- Other papers using this trial's data
- A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02061969. Randomized; no masking; primary purpose treatment. Start 2014-04-25 (registry gives no type); primary completion 2017-04-10 (actual). Results posted on 2018-08-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ADA Linagliptin in Long Term Care
- Condition
- Diabetes
- Intervention (Drug)
- linagliptin
- Intervention (Drug)
- insulin glargine
- Lead sponsor
- Emory University
- Collaborator
- American Diabetes Association
Record details
- Record id
cardio:ct-nct02061969- Content hash
1cd02f99eade219010382025e289e9a88166158acfb301bf67e05fe086605491